Skip to main content
. Author manuscript; available in PMC: 2015 Nov 12.
Published in final edited form as: Vaccine. 2014 Sep 20;32(48):6527–6536. doi: 10.1016/j.vaccine.2014.08.065

Fig. 5.

Fig. 5

Ex vivo replication of SHIV-2873Nip in cultured PBMC of ROb-12, the protected RM (boxed). PBMC were stimulated with Con A in the presence of IL-2. Unfractionated PBMC or CD8+ cell-depleted PBMC were exposed to SHIV-2873Nip, and replication was monitored by p27 ELISA of culture supernatants. As control, virus replication in PBMC (unfractionated or CD8+ cell-depleted) of one naïve RM (RSf-12) was also measured.